SHANGHAI FOSUN PHARMACEUTICAL (GROUP) earnings per share and revenue

600196 earnings per share for the last quarter are 0.29 CNY whereas the estimation was 0.29 CNY which accounts for -1.69% surprise. Company revenue for the same period amounts to 10.45 B CNY despite the estimated figure of 10.34 B CNY. Estimated earnings per share for the next quarter are 0.28 CNY, and revenue is expected to reach 10.84 B CNY. Also watch annual changes over time to get a bigger picture of 600196 earnings per share and revenue dynamics.